Answer to Question 1
Correct Answer: 1, 3, 4
Rationale 1: A deep intramuscular injection of medroxyprogesterone acetate (Depo-Provera) provides 3 months of contraceptive protection.
Rationale 2: Ethinyl estradiol and levonorgestrel (Alesse) is incorrect because it is a monophasic daily oral contraceptive.
Rationale 3: Ortho-Evra is a transdermal patch containing ethinyl estradiol and norelgestromin that is worn on the skin. The patch is changed every 7 days for the first 3 weeks, followed by no patch during week 4.
Rationale 4: NuvaRing is a 2-inch-diameter ring containing estrogen and progestin that is inserted into the vagina to provide 3 weeks of contraceptive protection. The ring is removed during week 4, and a new ring is inserted during the first week of the next menstrual cycle.
Rationale 5: Ortho-Novum 7/7/7 is incorrect because this is a triphasic daily oral contraceptive.
Global Rationale: A deep intramuscular injection of medroxyprogesterone acetate (Depo-Provera) provides 3 months of contraceptive protection. Ortho-Evra is a transdermal patch containing ethinyl estradiol and norelgestromin that is worn on the skin. The patch is changed every 7 days for the first 3 weeks, followed by no patch during week 4. NuvaRing is a 2-inch-diameter ring containing estrogen and progestin that is inserted into the vagina to provide 3 weeks of contraceptive protection. The ring is removed during week 4, and a new ring is inserted during the first week of the next menstrual cycle. Ethinyl estradiol and levonorgestrel (Alesse) is incorrect because it is a monophasic daily oral contraceptive. Ortho-Novum 7/7/7 is incorrect because this a triphasic daily oral contraceptive.
Answer to Question 2
Correct Answer: 1
Rationale 1: Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form.
Rationale 2: Using a topical preparation of the drug is incorrect. Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form.
Rationale 3: Taking a larger dose is incorrect. Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form.
Rationale 4: Using it on an as-needed basis is incorrect. Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form.
Global Rationale: Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form. Using a topical preparation of the drug is incorrect. Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form. Taking a larger dose is incorrect. Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form. Using it on an as-needed basis is incorrect. Doses of finasteride are five times higher when prescribed for BPH than when prescribed for baldness. To produce the best effects, schedule and dose should be regulated, and this medication only comes in oral form.